Skip to Content

Tag: ResMed


Also Noted

Product launches: ResMed, Tandem Diabetes Care 

February 13, 2024HME News Staff

ResMed has launched its AirCurve 11 series of bilevel devices. The AirCurve 11 uses two levels of support – inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP) –and is also built on the company’s AirSense 11 platform. Other features include integrated heated humidifier, engagement tools like AirView, myAir and Personal Therapy Assistant. “Patient care is our top priority, and that includes their comfort and compliance with PAP therapy,”...

AirCurve 11, ResMed, Tandem Diabetes Care, Tandem Mobi


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed on mask recall, big tech and demand-gen

January 26, 2024Liz Beaulieu, Editor

SAN DIEGO – ResMed CEO Mick Farrell said a recall of its CPAP masks with magnets did not impact the company’s sales for the second quarter ended Dec. 31, 2023.  ResMed in November issued an urgent field safety notice to patients detailing possible interference with its AirFit and AirTouch masks and certain medical devices; the company in December then announced a voluntary global field action to update its guides. The U.S. Food and Drug Administration in January classified...

CPAP, CPAP Mask, Mick Farrell, Recall, ResMed


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed results reflect ‘cost discipline’

January 25, 2024HME News Staff

SAN DIEGO – ResMed reported revenue of $1.2 billion for its second quarter ended Dec. 31, 2023, a 12% increase compared to the same period the previous year.  The company reported a net income of $208.8 million vs. $280.2 million.  “Our second-quarter fiscal year 2024 results reflect strong double-digit growth across our combined device, masks and accessories, and residential care software businesses, as well as cost discipline to support an acceleration in profitability,”...

ResMed


Read Full Articlered right arrow icon

News

In brief: Target exec joins VGM, FDA classifies ResMed recall 

January 17, 2024HME News Staff

WATERLOO, Iowa – VGM Fulfillment, a VGM Group company, has named Peter Martin, most recently group vice president – food supply chain for Target, as president.  Martin, who has lived in the Cedar Valley, where VGM is headquartered, will also join the company’s senior leadership team.  “Through an extensive interview process, Pete stood out as an incredible addition to VGM,” said Jeremy Stolz, CEO of VGM Group. “The HME industry is constantly evolving....

Peter Martin, ResMed, VGM Fulfillment, VGM Group


Read Full Articlered right arrow icon

Vendors

FDA classifies ResMed recall

January 15, 2024HME News Staff

WASHINGTON – The U.S. Food and Drug Administration has classified ResMed’s recall of CPAP masks with magnets a Class I recall, the most serious type.  ResMed in November issued an urgent field safety notice to patients detailing possible interference with its AirFit and AirTouch masks and certain medical devices. Then the company in December announced a voluntary global field action to update its guides.  “ResMed is recalling these masks to update the labels, add...

Recall, ResMed


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed starts tracking patients on both weight loss drugs, CPAP therapy

January 5, 2024Liz Beaulieu, Editor

YARMOUTH, Maine – ResMed CEO Mick Farrell believes that, based on the company’s early research, weight loss drugs will be a “net positive” for patient flow for sleep apnea.  “I mean, I think there's $1 trillion worth of market cap now from these (pharmaceutical) companies and they will turn that into marketing to bring people in for the miracle drug,” he said during a recent conference call to discuss ResMed’s latest financial results. “And...

CPAP, CPAP Device, Mick Farrell, ResMed, weight loss drugs


Read Full Articlered right arrow icon

Jason Jones

Specialty Providers

Providers report hiccups with ResMed

December 15, 2023Theresa Flaherty, Managing Editor

YARMOUTH, Maine – In the wake of a big layoff and an urgent field safety notice, ResMed could be doing a better job communicating, its provider customers say.  The company announced in October that it had reduced its global workforce by 5% to “accelerate profitable growth and power long-term success,” but it didn’t provide additional details on what positions were affected.   “We were going to be a beta tester for them and then, two days later, no...

CPAP, ResMed


Read Full Articlered right arrow icon

News

In brief: CPI-U increase, WOY finalists, ResMed lawsuit 

December 12, 2023HME News Staff

WASHINGTON – CMS has announced a 3% CPI-U adjustment to the DMEPOS fee schedule for calendar year 2024, AAHomecare has reported, but the actual amount will be influenced by Medicare’s competitive bidding program.  The adjustment varies as follows:     • CBP items in former CBAs (projected percentage change): +2.9%     • CBP items in non-CBAs (CPI-U): +3% (not directly stated in the change request)     • Non-CBP items...

Consumer Price Index (CPI), HME Woman of The Year, Patents, ResMed


Read Full Articlered right arrow icon

Mick Farrell

Also Noted

ResMed wins patent fight 

December 12, 2023HME News Staff

SAN DIEGO – The U.S. Patent Trial and Appeals Board (PTAB) has invalidated the claims that New York University asserted against ResMed in a complaint for patent infringement filed in U.S. District Court, District of Delaware, in June 2021. NYU’s complaint alleged that the AutoSet and AutoRamp features of ResMed’s AirSense 10 AutoSet flow generators infringed one or more claims of seven NYU patents. “At ResMed, we’re committed to providing patients with our leading therapy...

Patent infringement, ResMed


Read Full Articlered right arrow icon

Vendors

Study highlights danger of COPD in women 

December 11, 2023HME News Staff

SAN DIEGO – COPD prevalence among those 25 years and older is expected to increase by 23% from 2020 to 2050, with the largest growth projected among women and within low- and middle-income countries, according to a new study from ResMed published in the Journal of the American Medical Association (JAMA) Network Open.  Other results from the study:  By 2050, the number of women with COPD is projected to increase by 47% compared to only 9% growth in men   Low-...

COPD, Journal of the American Medical Association, ResMed


Read Full Articlered right arrow icon